hereditary cancer
Myriad Genetics Q1 Product Revenues Increase 3 Percent
The company reported revenues of $164.9 million, all of which came from its molecular testing business, beating analysts' consensus expectation.
Senate Bill Proposes to Expand Medicare Coverage for Hereditary Cancer Testing
Legislators sponsoring the bill hope the move will improve access to cancer screenings, preventative surgeries, and save lives.
Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access
Patients will now be able to order genetic testing and counseling from Invitae directly via Outcomes4Me's app.
Intermountain Gets National Stage, Myriad Adds Tumor Profiling Panel With Combined Test Offering
Premium
Although the logistics still need to be worked out, the partners hope to streamline oncologists' experience ordering tests that can inform patient care.
German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing
Premium
Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting.